Home Equities 3 Growth Stocks With Strong Earnings Forecasts and Healthy Balance Sheets
Equities

3 Growth Stocks With Strong Earnings Forecasts and Healthy Balance Sheets

Share


Global inflation, interest rate uncertainty and shifting energy and trade trends are keeping markets on their toes, yet analysts still see pockets of strong earnings growth ahead. The Healthy high growth potential screener filters for stocks where analysts expect solid earnings expansion over the next 3 years, while also checking that each company sits in an acceptable financial position. For investors who want growth potential without ignoring balance sheet strength, this can be a useful starting point. In this article, you will see 3 stocks from this screener that stand out for further research.

Remitly Global (RELY)

Overview: Remitly Global is a Seattle based fintech company that runs a digital platform and app for people sending money across borders, offering remittances and related financial services to customers in the United States, Canada and many other countries.

Operations: Remitly Global generates all of its US$1.73b revenue from data processing services linked to cross border payments, with around US$1.14b coming from customers in the United States, US$168.1m from Canada and US$414.7m from the rest of the world.

Market Cap: US$4.9b

Remitly Global stands out in this screener because it combines a focused digital remittance model with earnings growth forecasts that analysts see as materially above general market expectations, underpinned by expanding products like Remitly Business, multicurrency wallets and stablecoin functionality. The company is now profitable, with margin improvement linked to AI driven customer acquisition, fraud prevention and automation. Index inclusions and rising institutional interest are increasing its visibility. At the same time, investors need to weigh higher regulatory and competitive risks, heavy reliance on external borrowing and recent insider selling. For readers who want to understand how this balance of growth potential, quality indicators and real execution risks fits together, there is more to unpack in the detailed analysis that follows.

Remitly Global’s rapidly scaling digital remittance platform and new products like multicurrency wallets and stablecoin functionality are only half the picture; the real question is how analysts see this translating into future earnings strength through the analyst forecasts for Remitly Global

NasdaqGS:RELY Earnings & Revenue Growth as at Jul 2026
NasdaqGS:RELY Earnings & Revenue Growth as at Jul 2026

Kiniksa Pharmaceuticals International (KNSA)

Overview: Kiniksa Pharmaceuticals International is a biopharmaceutical company that develops and commercializes therapies for diseases with significant unmet need, led by ARCALYST for recurrent pericarditis and cardiac sarcoidosis, and supported by additional monoclonal antibody programs such as KPL-387 and KPL-116.

Operations: Kiniksa Pharmaceuticals International currently generates about US$754.0m in revenue from developing and delivering therapeutic medicines.

Market Cap: US$5.0b

Kiniksa Pharmaceuticals International is drawing attention because it couples a growing ARCALYST franchise and a focused cardiovascular pipeline with strong profitability metrics, including earnings growth forecasts above 20% a year and improving return on equity. At the same time, the stock trades on a high P/E multiple and depends heavily on a single product and on external funding, so any setback in prescribing trends, pricing or clinical data could hit both earnings and valuation hard. Recent index inclusions and earnings estimate upgrades highlight growing institutional interest. The key question for investors is whether ARCALYST’s growth potential, margin profile and pipeline prospects are sufficient to justify current expectations and funding risks over the long term.

Kiniksa Pharmaceuticals International’s ARCALYST story looks powerful, yet much of the debate still circles around a single product. To see how the wider pipeline and earnings expectations really line up, review the analyst forecasts for Kiniksa Pharmaceuticals International

NasdaqGS:KNSA Earnings & Revenue Growth as at Jul 2026
NasdaqGS:KNSA Earnings & Revenue Growth as at Jul 2026

Penguin Solutions (PENG)

Overview: Penguin Solutions is an enterprise hardware, software and services provider that builds and manages computing, memory and LED solutions for data centers, AI workloads and industrial customers, using brands such as Stratus for continuous-availability systems, SMART Modular for memory and storage, and Cree LED for lighting components.

Operations: Penguin Solutions generates about US$715.4m from Integrated Memory, US$543.1m from Advanced Computing and US$244.2m from Optimized LED products and services.

Market Cap: US$4.0b

Investors looking at AI infrastructure stocks may find Penguin Solutions interesting because AI related sales already represent a large share of revenue, supported by products like OriginAI and ClusterWareAI, as well as growing partnerships such as the NVIDIA AI Factory program. Recent quarters have featured record revenue, raised guidance and higher analyst targets. However, the stock still carries execution questions around lumpier large deals, tariff exposure in Optimized LED and the timing and payoff of heavy R&D in next generation memory. In addition, there is high reliance on external funding and recent insider selling, so Penguin Solutions offers a mix of fast growing AI exposure and real funding and volatility trade offs that may warrant closer inspection.

Penguin Solutions’ AI revenue mix and heavy R&D spend suggest a story that could be accelerating faster than many appreciate, but the real twist may sit inside the analyst forecasts for Penguin Solutions.

NasdaqGS:PENG Earnings & Revenue Growth as at Jul 2026
NasdaqGS:PENG Earnings & Revenue Growth as at Jul 2026

The three stocks in this article are just a starting point, as the full Healthy high growth potential screener surfaced 1,494 more companies with equally compelling growth and financial strength stories inside the Healthy high growth potential screener. Use Simply Wall St to identify, filter and analyze the specific catalysts and narratives that matter to you so you can focus on the highest conviction opportunities.

Take Control of Your Investment Journey

If Remitly Global or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen.
Once you’ve made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates.
Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives.
By uncovering hidden catalysts and risks early, you’ll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before They Fly?

Markets move fast, and the next breakout stocks rarely stay under the radar for long. Scan these fresh ideas before momentum is caught elsewhere, then act based on your own research and judgment.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.
It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We’ve created the ultimate portfolio companion for stock investors, and it’s free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com



Source link

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Top Global Dividend Stocks To Consider In July 2026

As global markets navigate mixed signals from economic data and sector-specific performances,...

High Growth Tech Stocks In Europe With Promising Potential

The European market has recently shown positive momentum, with the STOXX Europe...

Ballast Rock Asset Management Names Michael Welch Head Of Investor Relations And Capital Formation

Ballast Rock Asset Management has appointed Michael G. Welch, CFA, as Head...

Middle Eastern Dividend Stocks Including Abu Dhabi Islamic Bank PJSC And 2 More

Amid rising geopolitical tensions between the United States and Iran, most Gulf...